Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Pulmonology: What You May Have Missed in 2025
Yusing Gu1, Sandra Ragheb1, Michael Unger2
1McMaster University, Hamilton, Ontario, Canada (Y.G., S.R.).
Abstract:
Research in pulmonology generated several landmark publications over the past year. We screened more than 900 studies published in 2025 and selected 8 articles that highlight novel treatments and possible practice-changing evidence in several respiratory conditions. Two articles studied therapeutic options in interstitial lung disease, including a novel antifibrotic agent for pulmonary fibrosis and first-line methotrexate use in sarcoidosis. Two articles outlined the role of corticosteroids in community-acquired pneumonia and selecting patients who may benefit most. One article described evidence for an alternate agent for smoking cessation in patients with or without chronic obstructive pulmonary disease (COPD), while another article studied the use of mepolizumab in patients with eosinophilic COPD. We also reviewed the first head-to-head trial comparing biologic medications in asthma and chronic rhinosinusitis with nasal polyps. Finally, we summarized the latest evidence of a first-in-class therapeutic agent that reduced exacerbations in patients with bronchiectasis.
More Related Videos
Related Concept Videos
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

